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Abstract 
PICO Question 
In very low birth weight infants (VLBW), does the use of prophylactic probiotics decrease the 
incidence of necrotizing enterocolitis? 
Method 
Databases searched include PubMed, Cochrane, Medline, ScienceDirect, UpToDate, and 
CINAHL databases, resulting in 10 relevant articles (four meta-analyses, two systematic reviews, 
three randomized controlled trials, and one cohort study). 
Results 
The research concluded that overall there is a decrease in the incidence of NEC when VLBW 
infants are given prophylactic probiotics.  
Recommendations 
In conclusion, probiotics have shown efficacy in preventing NEC, and pose no observable 
adverse effects to VLBW infants. The final recommendation would be to implement the use of 
probiotics for VLBW infants. The conclusions strongly suggest a change in practice, and hospital 
NICUs would greatly benefit from the use of probiotics. 
Keywords: necrotizing enterocolitis, probiotics, preventative, prophylactic, very low birth 
weight, nursing 
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The Effectiveness of the Use of Probiotics in the Prevention of Necrotizing Enterocolitis 
Background 
Statistics and Definitions 
 Necrotizing Enterocolitis (NEC) is a gastrointestinal disease affecting approximately 
10% of all VLBW premature infants (Springer, 2014). In this disease process, mucosal integrity 
is lost, allowing the onset of infection in the bowel wall by colonizing bacteria such as 
Escherichia coli, Klebsiella, Clostridium perfringes, Staphylococcal epidermis and Rotavirus 
(Samanta, 2009). VLBW infants are categorized as those born weighing <1500 grams, and 
extremely low birth weight (ELBW) infants as those weighing <1000 grams. This EBP review 
will focus on only those in the VLBW category (1000-1499 g). Although it is possible for NEC 
to affect full term, appropriate for gestational age infants, the literature has shown that these are 
at far less risk for developing NEC than those born prematurely with very low birth weights. 
Mortality rates of 15% to 30% occur in VLBW infants who have developed NEC, depending on 
severity (Butte, 2014). Severity can be determined based on Modified Bell’s Staging for NEC. 
See Appendix C, Table 3 for stage detailing.  
Probiotics are defined as “microbial food supplements that beneficially affect the host by 
improving its intestinal microbial balance” (Gibson, 1995). These beneficial microbes typically 
include those of the Lactobacillus and Bifidobacteria genus, although others may be used. While 
breast milk is typically the first source of these probiotics, infants in the NICU undergo delayed 
colonization due to the heavy use of broad spectrum antibiotics, facilitating the development of 
NEC (Samanta, 2009). 
PICO Question 
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In very low birth weight infants, does the use of prophylactic probiotics decrease the risk 
of developing necrotizing enterocolitis? P: very low birth weight infants; I: prophylactic 
probiotics; C: no use of probiotics; O: prevention of necrotizing enterocolitis. 
Registered Nurse Interviews 
After discussion with several registered nurses who routinely work in the NICU, a few 
common themes began to arise. In the care of VLBW infants, the use of breast milk is often 
encouraged. Nurses also take frequent abdominal girth measurements and check gastric residual 
before each feeding. These three practices aid in the prevention and early detection of NEC. 
There were no policies pertaining to the particular issue of NEC at the facilities in which the RNs 
were employed. When asked about the use of probiotics as a preventative measure for NEC, 
none of the nurses had any previous knowledge about this potential prophylactic treatment.  
Search Methods 
 A literature search and review was conducted in October 2014. The search was intended 
to find peer-reviewed articles published in journals regarding the topic of probiotics and how 
their use is related to the prevention of NEC in infants. The online databases used for the search 
included CINAHL, Cochrane, Medline, PubMed, ScienceDirect, and UpToDate. The keywords 
used in all of the searches included “probiotics” and “necrotizing enterocolitis.” Other keyword 
variations used to narrow the search included “prophylactic,” “prevention,” “nursing,” “very low 
birth weight,” and “preterm.” Articles were included in the review of literature if they were 
specifically about probiotics being used prophylactically to prevent NEC in VLBW 
infants. Articles were excluded from the review if they were published before 2008, the full text 
was not available or not available in English, prebiotics were the main preventative measure, the 
study focused on ELBW infants, or if probiotics were not used prophylactically. 
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Results 
Critique 
 Our review included four meta-analyses and two systematic reviews (Appendix A, Table 
1A) and three individual RCTs and one cohort study (Appendix A, Table 1B). All of the studies 
were published within the last six years. The studies included in the review of literature had 
several basic similarities. Each study had the purpose of examining the relationship between the 
use of probiotics in the prevention of NEC in VLBW infants. Additionally, all of the studies 
classified the development of NEC as ≥ stage 2 according to Modified Bell Staging (Appendix 
C, Table 3). This classification represents definite cases of NEC as opposed to suspected cases 
(Schanler, 2014). The consistency found in these studies coincides with the purpose of this 
review. 
Synthesis 
 There were many overlapping findings between the studies reviewed. The decrease in the 
incidence of NEC when treated prophylactically with probiotics was determined by all studies 
included (AlFaleh & Anabrees, 2014; Bernardo et al., 2012; Braga et al., 2011; Deshpande et al., 
2010; Guthmann et al., 2010; Li et al., 2013; Lin et al., 2008; Rohan & Wainwright, 2014; 
Samanta et al., 2009; Wang et al., 2011). Multiple other factors were observed as well, such as 
decreased hospitalization time (Bernardo, et al., 2012; Samanta et al., 2009) and decreased time 
to full enteral feeds (Bernardo, et al., 2012; Braga, et al., 2011; Samanta et al., 2009). Adverse 
effects of probiotics have not been observed thus far in their use (AlFaleh & Anabrees, 2014; 
Braga et al., 2011; Guthmann et al., 2010; Li et al., 2013). One concern with the use of probiotics 
is the potential cause of sepsis by probiotic administration1; however, none of the studies 
included in this review found a significant link between probiotic administration and the 
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development of sepsis. Two articles (Guthmann et al., 2010; Rohan & Wainwright, 2014) made 
the observation that studies which administered a combination of multiple probiotics (as opposed 
to one strain) presented with better outcomes and lower percentages of the development of NEC. 
Samanta et al. (2009) noted that while the administration of probiotics lowered the incidence of 
NEC, it did not affect the severity of NEC developed. This emphasizes the use of probiotics as a 
preventative measure, not a treatment plan. For a summary of findings, implications, and 
recommendations of each study included, refer to Table 2 found in Appendix B. 
Discussion 
Study Model and Recommendations 
 The Iowa Model of Evidence-Based Practice to Promote Quality Care was used to guide 
this review to determine a topic of study and the relevance of the topic to nursing practice, as 
well as in the gathering and evaluation of the present literature (Titler et al., 2001). Due to the 
amount and level of evidence already present in the literature on this topic, more research is not 
necessary to establish the benefits of probiotic use in preventing NEC. As mentioned previously, 
probiotics have been shown to decrease length of hospital stay and time to full enteral feeds 
(Bernardo, et al., 2012; Samanta et al., 2009; Braga et al., 2011). This supports the use of 
probiotics in their cost-to-benefit ratio, as decreased hospitalization time will decrease cost of 
treatment. Additionally, probiotics are considered to be an easy-to-handle treatment that is also 
low cost (Bernardo et al., 2012), further validating their efficacy in hospital use.  
Probiotic use should become a standard in practice among neonatal intensive care units in 
the care of VLBW infants. Until these changes can be made and policies established, probiotics 
should be an informed option for parents of VLBW infants in the care of their child; however, 
more research is needed to evaluate the efficacy of specific types, combinations, and dosages of 
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probiotics required to be most beneficial and practical. Furthermore, there is a lack of research 
pertaining to the beneficial use of probiotics in ELBW infants, warranting further research. 
Limitations 
 This review focused on reducing the risk of NEC through prophylactic probiotic therapy, 
but it was found that each study mentioned several different types or combinations of probiotics. 
It was difficult to compare these strains and combinations because each study used a different 
combination or used a single strain for therapy. Furthermore, it could not be determined which 
probiotic was most effective, as none of the studies compared the efficacy of certain probiotics to 
others. Refer to Appendix D, Table 4 to see the specific types of probiotics, as well as the 
different combinations of probiotics that were used in each study.  
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Footnotes 
1Theoretically, because probiotic therapy is the intentional introduction of bacteria to the 
gastrointestinal system, overgrowth and potential sepsis could occur (Zupancic, 2009). One such 
case was reported by Land et al. (2005), who advocated for awareness of this complication but 
state that their “report should not discourage the appropriate use of […] probiotic agents.” 
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Appendix A 
Table 1A 
Meta-Analyses and Systematic Reviews Included 
Author/Date/
Type Purpose 
Number of 
RCTs 
Included 
Inclusion Criteria/Study 
Details Exclusion criteria LOE 
AlFaleh & 
Anabrees, 
2014, 
Systematic 
Review 
To analyze whether 
prophylactic probiotics are 
more effective than no 
treatment in the prevention 
of severe NEC and/or sepsis 
in preterm infants.  
24 RCTs Weight: <1500 g 
Gestational Age: <37 weeks 
NEC Staging: ≥stage 2 
Additional Criteria: Any 
trials that involved enteral 
administration of any live 
microbial supplement 
(probiotics), and measured at 
least one prespecified clinical 
outcome 
Studies that 
included bias and 
were not applicable 
1 
Bernardo et 
al., 2012, 
Meta-Analysis 
To demonstrate the 
advantages of probiotic use 
to prevent NEC and its 
consequences in preterm 
infants 
11 RCTs Weight: <1500 g 
Gestational Age: <34 weeks 
NEC Staging: ≥stage 2 
Additional Information: 
Infants ≥34 weeks may have 
been included if they were 
<1500 g at birth 
Studies that 
included patients 
with ≥34 weeks 
gestation and 
≥1500 g at birth, 
and studies in 
which it they did 
not establish limits 
1 
Deshpande et 
al., 2010, 
Meta-Analysis 
To update a previous 
systematic study by the same 
authors in order to see the 
effect of probiotic 
supplementation on NEC 
prevention 
11 RCTs Weight: <1500 g 
Gestational Age: <34 weeks 
NEC Staging: ≥stage 2 
Additional Criteria: enteral 
administration of any probiotic 
started within the 10th day of 
life and carried out for at least 
7 days 
No specific 
exclusion criteria 
listed 
1 
Guthmann et 
al., 2010, 
Meta-Analysis 
To provide an updated meta-
analysis including 2 new 
RCT studies since previous 
publication 
11 RCTs Weight: <1500 g 
NEC Staging: ≥stage 2 
Additional Information: 
RCTs included from previous 
analyses, including 2 newly 
published RCTs 
Any trials that were 
not prospective or 
controlled 
1 
Rohan & 
Wainwright, 
2014, 
Systematic 
Review 
Investigate whether use of 
probiotic use in premature 
and VLBW infants reduces 
the incidence of NEC 
7 RCTs Weight: <1500 g 
NEC Staging: ≥stage 2 
No specific 
exclusion criteria 
listed 
1 
Wang et al., 
2011, Meta-
Analysis 
Updated synthesis of the 
effects of probiotics in the 
prevention of necrotizing 
enterocolitis in preterm, very 
low birth weight infants 
20 RCTs Weight: <1500 g 
Gestational Age: <34 weeks 
NEC Staging: ≥stage 2 
Additional Criteria: 
probiotics administered within 
first 10 days of life for at least 
7 days 
Studies that did not 
have clinically 
relevant data 
1 
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Table 1B 
RCTs and Cohorts Included 
Author/Date
/Type Purpose Sample 
Key Variables 
Measured Treatment LOE 
Braga et al., 
2011, RCT 
To analyze the 
effectiveness of 
prophylactic 
combination probiotics 
in the prevention NEC 
Total sample size: 231 preterm infants  
Treatment: 119 infants 
Control: 112 infants 
Inclusion criteria: locally born 
neonates who were admitted to the 
NICU and weighed between 750 and 
1499 g at birth 
Exclusion criteria: major congenital 
malformations, previously diagnosed 
life-threatening chromosomal 
alterations, and/or congenital infections 
diagnosed at birth 
 - Incidence of 
NEC 
(Bell's stage ≥ 2) 
 - Sepsis 
 - Death 
 
The study group 
received 3 ml of 
human milk with 
added probiotics; 
the control group 
received the same 
volume of human 
milk minus the 
probiotics. 
2 
Li et al., 
2013, Cohort 
To analyze the 
effectiveness of 
prophylactic probiotics 
in the prevention NEC 
in VLBW infants in the 
NICU 
Total sample size: 580 
Control: 289 
Treatment: 291 
Inclusion criteria: VLBW infants who 
received at least 5 days of feeding or 
probiotics 
Exclusion criteria: early death, 
received inotropic support at birth for 
more than 3 days, or active 
gastrointestinal bleeding 
 - NEC (stage II or 
III) 
 - Death 
attributable to 
NEC 
 - Severity of NEC 
 - NEC scare 
A probiotic 
administration 
using a three-strain 
supplement was 
implemented.  
4 
Lin et al., 
2008, RCT 
To analyze the 
effectiveness of orally 
administrated 
prophylactic probiotics 
in the prevention of 
NEC in VLBW infants 
Total sample size: 434 infants 
Control: 217 
Treatment: 217 
Inclusion criteria: VLBW infants, <34 
weeks gestational age who survived to 
feed enterally 
Exclusion criteria: VLBW preterm 
infants with severe asphyxia, fetal 
chromosomal anomalies, cyanotic 
congenital heart disease, congenital 
intestinal atresia, gastroschisis or 
omphalocele, fed exclusively by 
formula, and who were fasted >3 weeks 
 - Death due to 
NEC 
 - NEC (Bell's 
stage ≥ 2; 
determination 
made by 2 
independent 
attending 
physicians who 
were unaware of 
the group 
assignment of the 
infant) 
Treatment group 
was administered 
probiotics, which 
were added to 
breast milk or 
mixed feeding 
(breast milk and 
formula) for 6 
weeks. 
2 
Samanta et 
al., 2009, 
RCT 
To analyze the 
effectiveness of 
probiotic in reducing 
food intolerance and 
reducing incidence and 
severity of NEC in pre-
term VLBW infants 
Total sample size:186 infants 
Control: 95 
Treatment: 91 
Inclusion Criteria: Preterm (<32 w), 
VLBW, born between October 2007 
and March 2008, who started feed 
enterally and survived beyond 48 hours 
of life 
Exclusion Criteria: babies with major 
congenital and GI anomalies and babies 
who expired due to other neonatal 
illnesses 
 - Days to reach 
full enteral feeding 
 - Duration of 
hospital stay 
 - Incidence of 
NEC (at least 
stage II) 
 - Sepsis 
 - Death rate 
Probiotics were 
added to breast 
milk for the 
treatment group. 
2 
Note. Specific probiotics used in each study are listed in Appendix D, Table 4. 
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Appendix B 
Table 2 
Key Findings and Implications/Recommendations of the Included Studies 
Author/Date Findings and Implications 
AlFaleh & 
Anabrees, 
2014 
Findings: Enteral supplementation of probiotics prevents severe NEC and all-cause mortality in preterm 
infants.  
Implications: More studies are needed to investigate the most effective formulation and dose to be 
utilized. Parents of preterm infants should be informed of current evidence if further RCTs are to be 
conducted. 
Bernardo et 
al., 2012 
Findings: Patients that received probiotic supplementation had lower food reintroduction time, 
hospitalization time, and incidence of NEC when compared to those not receiving probiotics. There was no 
difference in mortality caused by NEC or the severity of the disease.  
Implications: The use of probiotics is effective as a prophylactic treatment for NEC and its complications. 
Braga et al., 
2011 
Findings: More cases of NEC occurred in the control group than in the treatment group. The infants who 
received probiotics received enteral feeds sooner than the control group.   
Additional information: The study was stopped halfway through (one year into a planned two year study) 
because the External Study Committee determined that the positive results for the use of probiotics was 
established.  
Implications: Probiotics may prevent the development of NEC. 
Deshpande 
et al., 2010 
Findings: Fewer of the neonates who received probiotic treatment developed definite NEC (stage 2 or 
higher) as compared to those in the control group. The probiotic group demonstrated a decreased rate in 
death from all causes. 
Implications: Because of this evidence, Despande states “withholding probiotics from high-risk neonates 
is now almost unethical." 
Guthmann et 
al., 2010 
Findings: The incidence of NEC and mortality was reduced with the prophylactic use of probiotics. Trials 
that used multiple strains of probiotics tended to have further improved results.  
Implications: Probiotics can be used as an effective prophylactic treatment for NEC; however, local 
statistics on the incidence of NEC need to be considered. 
Li et al., 
2013 
Findings: Probiotics were shown to be safe and effective in the prevention of NEC for VLBW infants. 
There were no cases of infection related to this treatment.   
Implications: More research needs to be done since this study was observational. 
Lin et al., 
2008 
Findings: The incidence of death or NEC ≥ stage 2 was significantly lower in the treatment group.  No 
adverse effects were related to the probiotic treatment. 
Implications: Probiotics should be administered orally for six weeks reduce the incidence of NEC. 
Rohan & 
Wainwright, 
2013 
Findings: In the seven RCTs studied, there was a lack of consistency in the types, combinations, and 
dosages of probiotics used. The five RCTs that used multiple probiotic types all showed a decrease in NEC 
development while the two RCTs that tested the use of one probiotic did not demonstrate a beneficial 
outcome.  
Implications: Although results are promising, more research is needed regarding specific types, dosages, 
and combinations of probiotics before it becomes a routine practice. 
Samanta et 
al., 2009 
Findings: Administration of probiotics reduced incidence of NEC, number of days to enteral feedings, 
hospital stay, incidence of death, and sepsis, but did not significantly impact the severity of NEC when 
developed. 
Implications: Enteral administration of prophylactic probiotics in neonatal intensive care setup could 
significantly reduce morbidity due to NEC in VLBW newborns. 
Wang et al., 
2011 
Findings: Probiotic supplementation was shown to significantly reduce the risk for NEC and mortality in 
preterm VLBW infants. There was no significant difference in the risk for sepsis for those that used 
probiotics.  
Implications: Probiotic supplements should be included in regular, routine therapies for preterm infants. 
The optimum strain of probiotics and the long term effects need further study. 
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Appendix C 
Table 3 
Modified Bell’s Staging of Necrotizing Enterocolitis (Gordon et al., 2007) 
Review of 
Bell's stages Clinical findings Radiographic findings Gastrointestinal findings 
Stage I Apnea and bradycardia, temperature instability Normal gas pattern or mild ileus 
Gastric residuals, occult blood 
in stool, mild abdominal 
distention 
Stage II A Apnea and bradycardia, temperature instability 
Ileus gas pattern with one or 
more dilated loops and focal 
pneumatosis 
Grossly bloody stools, 
prominent abdominal distention, 
absent bowel sounds 
Stage II B Thrombocytopenia and mild metabolic acidosis 
Widespread pneumatosis, 
ascites, portal-venous gas 
Abdominal wall edema with 
palpable loops and tenderness 
Stage III A Mixed acidosis, oliguria, hypotension, coagulopathy 
Prominent bowel loops, 
worsening ascites, no free air 
Worsening wall edema, 
erythema and induration 
Stage III B 
Shock, deterioration in 
laboratory values and vital 
signs 
Pneumoperitoneum Perforated bowel 
 
Note. This chart was taken from Gordon et al. (2007); however, they adapted the chart based on 
the article by Kliegman and Walsh (1987), where a more comprehensive staging chart is 
provided. Bell’s Staging of NEC was first developed by Bell et al. in 1978, where there was no 
breakdown within stages, but simply stages I, II, and III. 
  
PROBIOTICS IN THE PREVENTION OF NEC 17 
Appendix D 
Table 4 
Probiotics Used in RCT and Cohort Studies Included 
Author/Date Probiotics Used in Experimental Group 
Braga et al., 2011 Lactobacillus casei, Bifidobacterium breve 
Li et al., 2013 
Streptococcus thermophilus, Bifidobacterium infantis, Bifidobacterium 
bifidum 
Lin et al., 2008 Bifidobacterium bifidum, Lactobacillus acidophilus 
Samanta et al., 
2009 
Bifidobacteria infantis, Bifidobacteria bifidum, Bifidobacteria longum, 
Lactobacillus acidophilus 
 
Note. Meta-Analyses and Systematic Reviews not included in the chart. See original studies for 
information on probiotics used in each individual study. 
